GMS Ventures & Investments

13F Holdings History for Outlook Therapeutics, Inc. - Common Stock, $0.001 par value per share (OTLK)

Symbol: OTLK on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value per share
Latest Disclosed Ownership: 29M shares
Security Ownership: 50.3%

GMS VENTURES & INVESTMENTS ownership in Outlook Therapeutics, Inc. Common Stock, $0.001 par value per share (OTLK)

2025-05-28 - GMS VENTURES & INVESTMENTS has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 29M shares of Outlook Therapeutics, Inc. Common Stock, $0.001 par value per share (OTLK). This represents 50.3% percent ownership of the company. In their previous filing dated 2025-03-12, GMS Ventures & Investments had reported owning 16.2M shares, indicating an increase of 79.4% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
GMS VENTURES & INVESTMENTS	50.3%	+20.7%	$45.3M	29M	+12,857,142	+79.4%	$1.56	13D/A	5/27/2025	28 May 2025 17:24:49
SUKHTIAN GHIATH M.	41.6%	+7.69%	$22.3M	16.2M	+3,458,571	+27.2%	$1.38	13D/A	3/11/2025	12 Mar 2025 21:11:16
GMS VENTURES & INVESTMENTS	38.6%		$17.6M	12.7M			$1.38	13D/A	1/17/2025	22 Jan 2025 16:17:28